Ciclesonide Patent Expiration
Ciclesonide is Used for treating inflammatory conditions, seasonal and perennial allergic rhinitis in adults and adolescents, and respiratory diseases in children. It was first introduced by Covis Pharma Gmbh
Ciclesonide Patents
Given below is the list of patents protecting Ciclesonide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Alvesco | US8371292 | Use of ciclesonide for the treatment of respiratory diseases | Feb 01, 2028 | Covis |
| Omnaris | US8371292 | Use of ciclesonide for the treatment of respiratory diseases | Feb 01, 2028 | Covis |
| Zetonna | US8371292 | Use of ciclesonide for the treatment of respiratory diseases | Feb 01, 2028 | Covis |
| Omnaris | US6767901 | Ciclesonide contained pharmaceutical composition for application to mucosa |
Oct 21, 2020
(Expired) | Covis |
| Omnaris | US8383611 | Ciclesonide containing aqueous pharmaceutical composition |
Oct 20, 2020
(Expired) | Covis |
| Omnaris | US6939559 | Pharmaceutical composition for application to mucosa |
Apr 21, 2019
(Expired) | Covis |
| Omnaris | US7235247 | Pharmaceutical composition for application to mucosa |
Apr 21, 2019
(Expired) | Covis |
| Alvesco | US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
May 13, 2018
(Expired) | Covis |
| Alvesco | US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds |
May 13, 2018
(Expired) | Covis |
| Zetonna | US6120752 | Medicinal aerosol products containing formulations of ciclesonide and related steroids |
May 13, 2018
(Expired) | Covis |
| Zetonna | US6264923 | Medicinal aerosol formulation of ciclesonide and related compounds |
May 13, 2018
(Expired) | Covis |
| Alvesco | US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
Oct 24, 2017
(Expired) | Covis |
| Omnaris | US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
Oct 24, 2017
(Expired) | Covis |
| Zetonna | US5482934 | Pregna-1,4-diene3,20-dione-16-17-acetal-21 esters, process for their preparation, composition, and methods for the treatment of inflammatory conditions |
Oct 24, 2017
(Expired) | Covis |
| Alvesco | US6006745 | Device for delivering an aerosol |
Dec 28, 2016
(Expired) | Covis |
| Zetonna | US6006745 | Device for delivering an aerosol |
Dec 28, 2016
(Expired) | Covis |
| Alvesco | US5775321 | Seal configuration for aerosol canister |
Jul 07, 2015
(Expired) | Covis |
| Zetonna | US5775321 | Seal configuration for aerosol canister |
Jul 07, 2015
(Expired) | Covis |
| Alvesco | US5683677 | Medicinal aerosol formulations |
Nov 04, 2014
(Expired) | Covis |
| Zetonna | US5683677 | Medicinal aerosol formulations |
Nov 04, 2014
(Expired) | Covis |
| Alvesco | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Covis |
| Zetonna | US5605674 | Medicinal aerosol formulations |
Feb 25, 2014
(Expired) | Covis |
| Alvesco | US6036942 | Seal configuration for aerosol canister |
Apr 30, 2013
(Expired) | Covis |
| Zetonna | US6036942 | Seal configuration for aerosol canister |
Apr 30, 2013
(Expired) | Covis |
Ciclesonide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List